Large-scale testing (Phase 3)Study completedNCT03434041
What this trial is testing
Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Who this might be right for
Depressive Disorder, Treatment-Resistant
Janssen Research & Development, LLC 252